![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.05 | 2.00 | 2.10 | 2.10 | 2.05 | 2.05 | 690,953 | 14:55:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.39 | 15.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2023 10:16 | Skots he was given 7M options to agree to stay until summer 2024. The implication is that he's leaving (or possibly retiring) at that point. | ![]() cyberbub | |
13/11/2023 10:12 | Where does it say he's leaving or is that your view cyber?Bollitix, the CEO and CFO made decision together the last two years so I still don't understand why you've always ranted at the CEO and loved the CFO. They were a leadership team and both been part of diluting and raising cash (and our current misery, which is still mostly the fault of previous CEOs)The CFO might have jumped disagreeing with strategy, just left for other reasons or been pushed, but none of us know the true story | ![]() skcots48 | |
12/11/2023 11:01 | Wrong bolitix.The CEO seens likely to be leaving next year, and has 7M free options to cash in. He has 7 millions reasons to get the share price as high as possible! | ![]() cyberbub | |
11/11/2023 07:29 | When you buy into this share you need to understand this CEO does not give a hoot about the share price He is all about drumming up cash to keep his environment running. I don't think that is a bad thing but the sensitivity of his donkey timing is painful. I think most of us had the chance to average down and new investors have a great punt at less than 6p going forward | ![]() bolitix | |
07/11/2023 12:07 | Am back in with 100k bought at 6.14p. Near enough to 6p for me to be confident we near the bottom support. Time will tell. | ![]() hamhamham1 | |
06/11/2023 07:43 | Awww bless. Another loser who buys on the spikes, sells at the bottom, and then forever blames the management. Move on. | ![]() the imperialist | |
05/11/2023 13:13 | 6p to 12p Then back to 12p. Endless cash raises. And the FD now leaving. Is this share just a complete load of rubbish or am I missing anything? | ![]() smithie6 | |
05/11/2023 12:24 | Apologies for the off topic folks but as it's out of hours. Devon, have you cast an eye over DEST ? | ![]() captain james t kirk | |
03/11/2023 16:00 | 13p is the technical level. Even if we're going to 5p, we go to 13p first. | ![]() the imperialist | |
03/11/2023 15:59 | Not sure what you are 'whating' qipincha, but if you're referring to my post 13074 I'm saying I believe a move to 8p+ COULD be on the horizon very soon (now the sellers are exhausted) and if so it MAY happen fairly quickly as we have seen with previous moves from this level. | ![]() parob | |
03/11/2023 14:06 | Market cap is currently just £47M. Should the Q3 results match expectations I'm half expecting an offer to come in whilst it's so cheap. | ![]() parob | |
03/11/2023 14:05 | Here it comes..... DYOR | ![]() the imperialist | |
03/11/2023 13:57 | Not saying this is definitely going to happen but if you look back at the chart there have been several occasions when the share price has consolidated around the 6p level then out of nowhere has shot back to 8p (and beyond) in a matter of days. Company has never been so advanced and we are hopefully due a Q3 update soon, hence I've averaged down a touch today. Certainly no worries about funding at the mo, and the markets are starting to turn more bullish so hopefully STX will also benefit. | ![]() parob | |
02/11/2023 16:48 | What's more rewarding I'm short 2 of your stocks Both red today While the FTSE is up over a 100 points !! | ![]() amaretto1 | |
31/10/2023 21:33 | Your VLS ? Very smart | ![]() amaretto1 | |
31/10/2023 18:57 | I'm not worried about the Rx numbers, I'm confident they will be rocketing. The problem is the GTN. We need to see that starting to climb significantly by the new year, to give confidence that they won't need any more money, or least not at the current share price. | ![]() cyberbub | |
31/10/2023 17:55 | So end 4q22 22 people make 9249 sales so 1 person per Q was 420. So for 100 embedded staff by 3Q23 the forecasted 28,454 sales could be nearer the 42k sales to equal the 4q22 rate. I am not surprised the forecasted 4Q23 at 51,217 either. Given the prescriber access went up nearly 4 fold then the 100k per Q rate they need to meet their YE24 prediction of 370-420k sales is easily within reach while their 550-600k sales for YE25 should be achievable. | ![]() bolitix | |
30/10/2023 16:17 | Could be a fantastic update locked-in and ready to roll at 7am. | ![]() the imperialist | |
30/10/2023 16:03 | Has that bleeding' cat escaped from the bag again? | ![]() rustyke1 | |
30/10/2023 14:54 | Follow the smart money. | ![]() the imperialist | |
30/10/2023 14:35 | ...looks like some have already seen it given the price action. | ![]() the imperialist | |
30/10/2023 13:43 | Q3 update should be close now… | ![]() rhatton |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions